Could a common diabetes drug melt heart fat and boost cardiac function?
NCT ID NCT02042664
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether GLP-1 receptor agonists, a type of diabetes drug, can improve heart function and reduce fat around the heart in 44 obese adults with type 2 diabetes. Participants received the drug BYETTA along with metformin. Researchers used MRI scans to measure heart fat and function. The goal was to see if this treatment could lower heart risks beyond just controlling blood sugar.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GLP-1 receptor agonist (exenatide/BYETTA)
What this could lead to
If successful, this could show that GLP-1 drugs improve heart function and reduce dangerous fat around the heart in obese diabetics.
What could go wrong
This is a small, completed Phase 3 trial with only 44 participants, so results may not apply to everyone. The study focused on heart imaging changes, not long-term health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France